-transparent.png){kind=logo}
The human immunodeficiency virus type 1 (HIV-1) belongs to the family of positive-stranded, enveloped RNA viruses with a DNA intermediate step (retroviruses). Because of the lack of fidelity of the reverse transcriptase (RT), the replication is error-prone, and the infection is characterized by its quasi-species nature. Antiretroviral treatment with such compounds as zidovudine (AZT), zalcitabine (ddC), didanosine (ddI), stavudine (d4T), and lamivudine (3TC) select for quasispecies variants that are resistant to these compounds (1). The detection of these variants is clinically important because they may affect the outcome of the treatment (2).
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
May 2000,
AIDS (London, England),
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
November 1987,
Lancet (London, England),
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
January 1993,
Journal of virological methods,
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
June 2002,
Antiviral therapy,
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
January 2007,
AIDS (London, England),
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
August 2000,
Journal of virological methods,
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
October 2008,
The Journal of biological chemistry,
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
July 1998,
Journal of clinical microbiology,
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
October 1996,
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
L Stuyver, and
A Wyseur, and
G Verpooten, and
R Rossau
January 1991,
Journal of virological methods,
